Resources

In part 8, the conclusion of this Exclusive Interview, John Buse talks with Diabetes in Control Publisher Steve Freed about the good and bad effects of using SGLT2 for patients who have type 1.

Researchers find increased risk in people with type 1 who have glucose levels greater than 8.0%.

More accurate genes to screen for type 1 diabetes in both newborns and adults identified.

Is it true that individuals paying for diabetes care and management using fee-for-service clinics may have better outcomes in their glucose levels?

People with diabetes can benefit from a lower portion of carbohydrates in their diet, but this adjustment may lead to other risks.

Can sitting for just 3 hours non-stop at one time hurt the heart?

Based on a meta-analysis of cardiovascular outcomes in type 2 diabetes studies, the findings suggest that a 15% relative risk reduction in nonfatal myocardial infarcts is associated with an A1c reduction of approximately:

A. .50%
B. 1.0%
C. 1.5%
D. 2.0%

Follow the link for the answer.

Do you refer adult patients for T2D prevention? Follow the link to see how you compare to your colleagues.

Woman, 55 years of age visited with me 3 weeks ago. Her glucose levels were in the 200-250 mg/dL range. She was actually a new patient of ours; her A1C was 9.2%. We recommended a CGM. She purchased one and brought it to the office for me to teach her how to use it. I did so. This patient is well-educated and seemed tech-savvy. When she left the visit, she "seemed" to understand CGM, what it is, what to do, and how to insert the sensor, get readings, interpret readings, etc.

Lisa M. Latts MD, MSPH, MBA, FACP is Deputy Chief Health Officer for IBM Watson Health. She is a national leader in health care quality and has nearly 20 years’ experience in health care delivery working to improve lives for patients.  She has worked as a health insurance executive, a consultant and for one of the nation’s leading academic medical centers helping to deliver high quality care to its faculty and employees. She is currently helping IBM Watson Health bring cognitive computing and machine learning to advance the idea of Value-Based Care and help solve the pressing problems that physicians, employers and payers are facing.